1150 Railway Ave, Weyburn, SK S4H 0B3     

michaelmclean@tribunecapital.ca | 403-389-9832

© 2019 Tribune Capital

Portfolio

MTI specializes in innovative metabolomics-based diagnostics for the healthcare market. Their product PolypDx is the first and only urine-based test for detection of adenomatous polyps – the precursor to colorectal cancer.